In 2018, the antihyperglycemic therapy of type 2 diabetes takes account of the cardiovascular risk: review of the American Diabetes Association guidelines

Martin Buysschaert Published in the journal : May 2018 Category : Congrès UCL de Médecine Générale

Summary :

New guidelines for the treatment of type 2 diabetes have recently been published by the American Diabetes Association.
This article was aimed at analyzing these recommendations in light of recent scientific data, including cardiovascular results.

Key Words

Type 2 diabetes, treatment, macroangiopathy, GLP-1 agonists, SGLT-2 inhibitors

What does this article bring up for us?

The therapeutic approach for type 2 diabetes is very well structured. However, a new treatment algorithm has recently been published, partly basing on the cardiovascular effects of newer and older antihyperglycemic agents.